Acute kidney injury and adverse renal events in patients receiving SGLT2-inhibitors: A systematic review and meta-analysis

BACKGROUND: Sodium-glucose cotransporter-2 inhibitors (SGLT2is) represent a new class of oral hypoglycemic agents used in the treatment of type 2 diabetes mellitus. They have a positive effect on the progression of chronic kidney disease, but there is a concern that they might cause acute kidney inj...

Descripción completa

Detalles Bibliográficos
Autores principales: Menne, Jan, Dumann, Eva, Haller, Hermann, Schmidt, Bernhard M. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901179/
https://www.ncbi.nlm.nih.gov/pubmed/31815931
http://dx.doi.org/10.1371/journal.pmed.1002983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901179/
https://www.ncbi.nlm.nih.gov/pubmed/31815931
http://dx.doi.org/10.1371/journal.pmed.1002983

Ejemplares similares